Scope

The Biology & Pharmaceuticals is multidiciplinary journal that welcomes manuscripts covering a wide range of aspects involved in drug discovery and development. The following topics are considered:

Small molecules as drug candidates: drug discovery, drug design, medicinal chemistry, combinatorial chemistry, SAR, structure-property correlations, molecular modeling, pharmacophore, and bioinformatics;
Biomolecules, natural products, phages, and cells as therapeutic tools: peptides, aptamers, glycans, antibodies, extracts, bacteriophages, and stem cells;
Biological targets and biomarkers: enzymes, receptors, membranes, genes, ion channels, inhibitors, agonists, antagonists, neurons, binding affinity, biofilms, bacteria, viruses, parasites, and protein–protein interactions;
Radiopharmaceutical sciences, radiochemistry, (hybrid-)imaging, and nuclear medicine: radiopharmaceuticals, radiotracers, fluorescent dye labeled tracers, contrast agents, PET/CT, PET/MRI RMI, SPECT/CT, and scintigraphy;
Pharmacokinetics and pharmacodynamics: pharmaceutical analyses, drug effects, ADME, animal experimentation, and clinical trials;
Pharmaceutical preparations and drug delivery: dosage form design, bioconjugates, prodrugs, formulation, metabolites, nanomaterials, nanomedicines, and drug targeting.

Biological Science

• Agricultural science

• Biomaterials and Bioactive polymers

• Biochemistry,

• Biotechnology,

• Bioinformatics,

• Cell biology,

• Developmental biology,

• Environmental biology,

• Genetics,

• Microbiology,

• Molecular and structural biology,

• Bioallied Sciences

•  

Pharmaceutical Science

• Pharmaceutics and Biopharmaceutics

• Novel and Targeted Drug Delivery

• Nanotechnology and Nanomedicine

• Pharmaceutical Chemistry

• Pharmacognosy and Ethanobotany

• Phytochemistry

• Pharmacology and Toxicology

• Pharmacogenomics

• Pharmacovigilance

• Natural Product Research

• Drug Regulatory Affairs

• Case Study and Full clinical trials